Repealing Drug Price Negotiation Powers from the Inflation Reduction Act.
This bill proposes to completely repeal the prescription drug price control provisions established by the Inflation Reduction Act (IRA). If enacted, the federal government would lose its authority to negotiate the prices of certain high-cost drugs, potentially affecting healthcare costs for citizens, particularly Medicare beneficiaries. This action restores the previous framework for drug pricing.
Key points
Eliminates the government's power to negotiate prices for expensive prescription drugs under the Medicare program.
Restores prior drug pricing rules, which may result in higher costs for patients and the healthcare system compared to the IRA provisions.
Expired
Citizen Poll